These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. Davatchi F, Sadeghi Abdollahi B, Shams H, Shahram F, Nadji A, Chams-Davatchi C, Faezi T, Akhlaghi M, Ghodsi Z, Ashofteh F, Mohtasham N. Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325 [Abstract] [Full Text] [Related]
7. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. Gül A, Tugal-Tutkun I, Dinarello CA, Reznikov L, Esen BA, Mirza A, Scannon P, Solinger A. Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392 [Abstract] [Full Text] [Related]
8. Uveitis in Behçet disease: an analysis of 880 patients. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218 [Abstract] [Full Text] [Related]
13. The role of azathioprine in the management of retinal vasculitis. Greenwood AJ, Stanford MR, Graham EM. Eye (Lond); 1998 Sep; 12 ( Pt 5)():783-8. PubMed ID: 10070509 [Abstract] [Full Text] [Related]
14. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases]. Niessen F, Campinchi R, Bloch-Michel E. J Fr Ophtalmol; 1982 Sep; 5(6-7):407-16. PubMed ID: 7130629 [No Abstract] [Full Text] [Related]
17. [Clinical observation of 85 patients with Behçet's uveitis treated with immunosuppressive agents combined with steroids]. Zhao M, Wang H, Jiao X, Wei WB. Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):202-6. PubMed ID: 23866699 [Abstract] [Full Text] [Related]